A detailed history of Black Rock Inc. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 13,983,662 shares of ESPR stock, worth $32.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,983,662
Previous 2,838,820 392.59%
Holding current value
$32.2 Million
Previous $7.61 Million 308.03%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.84 - $3.24 $20.5 Million - $36.1 Million
11,144,842 Added 392.59%
13,983,662 $31 Million
Q1 2024

May 10, 2024

BUY
$2.02 - $3.02 $1.47 Million - $2.19 Million
725,921 Added 34.36%
2,838,820 $7.61 Million
Q4 2023

Feb 13, 2024

BUY
$0.73 - $3.08 $105,864 - $446,661
145,020 Added 7.37%
2,112,899 $6.32 Million
Q3 2023

Nov 13, 2023

BUY
$0.96 - $1.79 $634,009 - $1.18 Million
660,427 Added 50.51%
1,967,879 $1.93 Million
Q2 2023

Aug 11, 2023

SELL
$1.2 - $1.76 $4.22 Million - $6.19 Million
-3,515,736 Reduced 72.89%
1,307,452 $1.82 Million
Q1 2023

May 12, 2023

SELL
$1.46 - $7.3 $1 Million - $5.01 Million
-685,999 Reduced 12.45%
4,823,188 $7.67 Million
Q4 2022

Feb 13, 2023

BUY
$5.09 - $8.5 $4.84 Million - $8.08 Million
950,543 Added 20.85%
5,509,187 $34.3 Million
Q3 2022

Nov 14, 2022

BUY
$5.45 - $8.13 $1.44 Million - $2.15 Million
264,412 Added 6.16%
4,558,644 $30.5 Million
Q2 2022

Aug 12, 2022

BUY
$4.77 - $6.67 $2.53 Million - $3.54 Million
530,492 Added 14.09%
4,294,232 $27.3 Million
Q1 2022

May 12, 2022

BUY
$3.34 - $5.56 $5.09 Million - $8.47 Million
1,522,523 Added 67.93%
3,763,740 $17.5 Million
Q4 2021

Feb 10, 2022

BUY
$4.81 - $11.92 $1.13 Million - $2.8 Million
235,083 Added 11.72%
2,241,217 $11.2 Million
Q3 2021

Nov 09, 2021

SELL
$11.34 - $21.37 $898,275 - $1.69 Million
-79,213 Reduced 3.8%
2,006,134 $24.2 Million
Q2 2021

Aug 11, 2021

BUY
$19.4 - $28.71 $40.5 Million - $59.9 Million
2,085,347 New
2,085,347 $44.1 Million

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $153M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.